Dr. Reddy's Labs Files 6-K
Ticker: RDY · Form: 6-K · Filed: Aug 7, 2024 · CIK: 1135951
Sentiment: neutral
Topics: sec-filing, foreign-private-issuer, administrative
Related Tickers: RDY
TL;DR
Dr. Reddy's Labs filed a 6-K, confirming their HQ in India and 20-F filing status.
AI Summary
Dr. Reddy's Laboratories Ltd. filed a Form 6-K on August 7, 2024, to report information as a foreign private issuer. The filing confirms their principal executive office is located at 8-2-337, Road No. 3, Banjara Hills, Hyderabad, Telangana, India, and that they file annual reports under Form 20-F.
Why It Matters
This filing is a routine disclosure for foreign private issuers, providing an update on their reporting status and administrative details to the SEC.
Risk Assessment
Risk Level: low — This is a standard administrative filing for a foreign private issuer and does not contain material financial or operational news.
Key Players & Entities
- DR REDDYS LABORATORIES LTD (company) — Filer
- 0001575872-24-000884 (filing_id) — Accession Number
- August, 2024 (date) — Filing Date
- 8-2-337, Road No. 3, Banjara Hills Hyderabad, Telangana 500 034, India (address) — Principal Executive Office
- Form 20-F (document) — Annual Report Filing Type
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, used to furnish information to the SEC.
Where is Dr. Reddy's Laboratories Ltd.'s principal executive office located?
Dr. Reddy's Laboratories Ltd.'s principal executive office is located at 8-2-337, Road No. 3, Banjara Hills, Hyderabad, Telangana 500 034, India.
Does Dr. Reddy's Laboratories Ltd. file annual reports under Form 20-F or 40-F?
Dr. Reddy's Laboratories Ltd. indicates that it files annual reports under cover of Form 20-F.
What is the filing date of this Form 6-K?
This Form 6-K was filed on August 7, 2024.
What is the company's Central Index Key (CIK)?
The company's Central Index Key (CIK) is 0001135951.
Filing Stats: 402 words · 2 min read · ~1 pages · Grade level 16.7 · Accepted 2024-08-07 11:31:55
Filing Documents
- drr0656_6k.htm (6-K) — 14KB
- drr0656_ex99-1.htm (EX-99.1) — 22KB
- drr0656_ex99-1img01.jpg (GRAPHIC) — 8KB
- drr0656_ex99-1img02.jpg (GRAPHIC) — 8KB
- drr0656_ex99-1img03.jpg (GRAPHIC) — 9KB
- 0001575872-24-000884.txt ( ) — 71KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. DR. REDDY’S LABORATORIES LIMITED (Registrant) Date: August 07, 2024 By: /s/ K Randhir Singh Name: K Randhir Singh Title: Company Secretary 3